Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S. officials are pressing the company to pay royalties linked to the ...
March 25 (Reuters) - BioNTech (22UAy.DE), opens new tab said on Monday the U.S. National Institutes of Health has sent a notice to the German company regarding default on the payment of royalties and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback